| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |